NURS 6521 Week 3 Assignment: Asthma And Stepwise Management

NURS 6521 week 3 Assignment

Asthma is a respiratory disorder that affects children and adults. Advanced practice nurses often provide treatment to patients with these disorders. Sometimes patients require immediate treatment, making it essential that you recognize and distinguish minor asthma symptoms from serious, life-threatening ones. Since symptoms and attacks are often induced by a trigger, advanced practice nurses must also help patients identify their triggers and recommend appropriate management options. Like many other disorders, there are various approaches to treating and managing care for asthmatic patients depending on individual patient factors.

One method that supports the clinical decision-making of drug therapy plans for asthmatic patients is the stepwise approach, which you explore in this NURS 6521 week 3 Assignment.

To Prepare

Reflect on drugs used to treat asthmatic patients, including long-term control and quick-relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.
Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.
Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Nrs 437v week 3 Assignment

By Day 7 of Week 3

Create a 5- to 6-slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following:

Describe long-term control and quick-relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.
Explain the stepwise approach to asthma treatment and management for your patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific. NURS 6521 week 2 Assignment.

Submission and Grading Information

To submit your completed Assignment for review and grading, do the following:

Please save your Assignment using the naming convention “WK3Assgn+last name+first initial.(extension)” as the name.
Click the Week 3 Assignment Rubric to review the Grading Criteria for the Assignment.
Click the Week 3 Assignment link. You will also be able to “View Rubric” for grading criteria from this area.
Next, from the Attach File area, click on the Browse My Computer button. Find the document you saved as “WK3Assgn+last name+first initial.(extension)” and click Open.
If applicable: From the Plagiarism Tools area, click the checkbox for I agree to submit my paper(s) to the Global Reference Database.
Click on the Submit button to complete your submission.

NURS_6521_Week3_Assignment_Rubric

	Excellent	Good	Fair	Poor
Describe the long-term control and quick-relief treatment options for the asthma patient from your practice, as well as the impact these drugs might have on your patient.	Points Range: 27 (27%) – 30 (30%) The presentation clearly and accurately describes in detail the long-term control and quick-relief treatment options for asthma patients from their practice. The presentation clearly and accurately describes in detail the impact these drugs might have on their patient.	Points Range: 24 (24%) – 26 (26%) The presentation accurately describes the long-term control and quick relief options for asthma patients in their practice. The presentation accurately describes the impact these drugs might have on their patient.	Points Range: 21 (21%) – 23 (23%) The presentation inaccurately or vaguely describes the long-term control and quick relief options for the asthma patient from their practice. The presentation inaccurately or vaguely describes the impact these drugs might have on their patient.	Points Range: 0 (0%) – 20 (20%) The presentation inaccurately and vaguely describes the long-term and quick relief options for the asthma patient from their practice or is missing. The presentation inaccurately and vaguely describes the impact these drugs might have on their patient, or is missing.
Explain the stepwise approach to asthma treatment and management for your patient.	Points Range: 27 (27%) – 30 (30%) The presentation clearly and accurately explains in detail the stepwise approach to asthma treatment and management for their patient.	Points Range: 24 (24%) – 26 (26%) The presentation accurately explains the stepwise approach to asthma treatment and management for their patient.	Points Range: 21 (21%) – 23 (23%) The presentation inaccurately or vaguely explains the stepwise approach to asthma treatment and management for their patient.	Points Range: 0 (0%) – 20 (20%) The presentation inaccurately and vaguely explains the stepwise approach to asthma treatment and management for their patient.
Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.	Points Range: 27 (27%) – 30 (30%) The presentation clearly and accurately explains in detail how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. The presentation provides accurate and detailed examples to support the explanation provided.	Points Range: 24 (24%) – 26 (26%) The presentation accurately explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. The presentation provides accurate examples to support the explanation provided.	Points Range: 21 (21%) – 23 (23%) The presentation inaccurately or vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. The presentation provides inaccurate or vague examples to support the explanation provided.	Points Range: 0 (0%) – 20 (20%) The presentation inaccurately and vaguely explains how stepwise management assists health care providers and patients in gaining and maintaining control of the disease or is missing. The presentation provides inaccurate and vague examples to support the explanation provided or is missing.
Written Expression and Formatting – Paragraph Development and Organization: Paragraphs make clear points that support well-developed ideas, flow logically, and demonstrate a continuity of ideas. Sentences are carefully focused–neither long and rambling nor short and lacking substance.	Points Range: 5 (5%) – 5 (5%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity.	Points Range: 4 (4%) – 4 (4%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time.	Points Range: 3.5 (3.5%) – 3.5 (3.5%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%–79% of the time.	Points Range: 0 (0%) – 3 (3%) Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time.
Written Expression and Formatting – English writing standards: Correct grammar, mechanics, and proper punctuation	Points Range: 5 (5%) – 5 (5%) Uses correct grammar, spelling, and punctuation with no errors	Points Range: 4 (4%) – 4 (4%) Contains a few (1–2) grammar, spelling, and punctuation errors	Points Range: 3.5 (3.5%) – 3.5 (3.5%) Contains several (3–4) grammar, spelling, and punctuation errors	Points Range: 0 (0%) – 3 (3%) Contains many (≥ 5) grammar, spelling, and punctuation errors that interfere with the reader’s understanding

Total Points: 100

SAMPLE SOLUTION

NURS 6521 week 3 Assignment Asthma and Stepwise Management

Asthma is a respiratory disease that causes the inflammation of the airways and the lungs
It affects over 400 million people globally (Khalid, 2015).
Major symptoms associated with the disease include shortness of breath, coughing, and wheezing
Common asthma triggers are allergens like dust mites, drugs like aspirin, viral infections, exercise, tobacco, and other nicotine-enhanced products
Various approaches are used to control the disease including long-term control and quick-relief treatment options (Choby & Lee, 2015).

LONG-TERM TREATMENT OPTIONS

The main purpose of the long-term treatment option is to prevent exacerbation of symptoms as well as control asthma
This option is most effective in the prevention of asthma attacks and chronic symptom control
Specific medications used for long-term treatment include long-acting beta-agonists, inhaled corticosteroids, theophylline, and leukotriene modifiers (Sobieraj et al, 2018).
All these medications are effective but inhaled corticosteroid is more effective in long-term control.

QUICK-RELIEF TREATMENT OPTIONS

Quick-relief medications also called fast-acting or rescue medications are used to relieve symptoms of asthma
They work fast to control major asthmatic symptoms which include shortness of breath, wheezing, and coughing
Specific medications used for quick relief treatment include Albuterol, Pirbuterol, Terbutaline, Metaproterenol, and Bitolterol ( Magee, Pittman& Jette-Kelly, 2018).
These medications work by relaxing the airway muscles thus eliminating the symptoms faster.
That is why they are known as bronchodilators

DRUG IMPACT ON PATIENT

Both long-term and quick-relief medications play a critical role to control and manage asthma
However, there are specific effects associated with them
They include hoarseness, thrush and coughing as the long-term treatment options.
In children, they also cause delayed or suppressed growth.
headaches, restlessness, anxiety, tremors, and uneven and fast heartbeats are common effects associated with quick-relief medications.

STEPWISE TREATMENT AND MANAGEMENT APPROACH

A stepwise approach is critical in deciding the step of therapy to use that coincides with the severity level of asthma
There are six primary steps involved in the stepwise approach.
Step one entails the use of a short-acting beta-agonist to address intermittent asthma
Step two, three, four, five, and six involves treatment of persistent asthma by taking daily medication.
The main difference between these five steps is the recommended dosage.
Low-dose inhaled corticosteroids(ICS) for step 2, medium-dose ICS for step 3, LABA, and medium-dose ICS for step 4, LABA and high-dose ICS for step 5, and oral corticosteroid, LABA plus, and high-dose ICS for step 6 (Holt 2016).

GAINING AND MAINTAINING CONTROL OF ASTHMA

A stepwise approach is an instrumental tool in helping both the healthcare providers and the patients gain and maintain control of asthma.
Healthcare providers are able to determine the severity level of asthma as well as the treatment options to use to attain asthma control.
The stepwise approach also involves patient education which is critical in helping the patient identify triggers, symptoms and also how to manage their condition individually
The approach is significant in guiding the providers and the patient the effective action plans to control and manage asthma.

REFERENCES

Choby, G. W., & Lee, S. (2015, September). Pharmacotherapy for the treatment of asthma: current treatment options and future directions. In International forum of allergy & rhinology (Vol. 5, No. S1, pp. S35-S40).

Holt TO. (2016). Stepwise approach to asthma management. RT: The Journal for Respiratory Care Practitioners, 22(5), 12–17.

Khalid, A. N. (2015). Stepwise management of asthma. International Forum of Allergy & Rhinology, 5 Suppl 1, S41–S44. https://doi-org.lopes.idm.oclc.org/10.1002/alr.21606

Magee, J. S., Pittman, L. M., & Jette-Kelly, L. A. (2018). Paradoxical Bronchoconstriction with Short-Acting Beta Agonist. The American Journal of Case Reports, 19, 1204–1207. https://doi-org.lopes.idm.oclc.org/10.12659/AJCR.910888

Sobieraj, D. M., Weeda, E. R., Nguyen, E., Coleman, C. I., White, C. M., Lazarus, S. C., … & Baker, W. L. (2018). Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a systematic review and meta-analysis. Jama, 319(14), 1485-1496.